Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines

Patients with HPV-positive head and neck squamous cell carcinoma (HNSCC) show better survival rates than those with HPV-negative HNSCC. While an enhanced radiosensitivity of HPV-positive tumors is clearly evident from single modality treatment, cisplatin is never administered as monotherapy and ther...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Busch, Chia-Jung, Becker, Benjamin, Kriegs, Malte, Gatzemeier, Fruzsina, Krüger, Katharina, Möckelmann, Nikolaus, Fritz, Gerhard, Petersen, Cordula, Knecht, Rainald, Rothkamm, Kai, Rieckmann, Thorsten
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5094966/
https://ncbi.nlm.nih.gov/pubmed/27127883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9028
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak